Scientific Program (Hybrid Format)

Melioidosis and Glanders

Monday, May 16th, 2022

2:00-6:00 pm

Registration open

3:00-5:00 pm

International Melioidosis Committee closed meeting

6:00 pm

Welcome reception

Tuesday, May 17th, 2022

7:30 am

Registration open

8:30-8:45 am


8:45-10:15 am


Invited Speakers

8:45 am

Bart Currie, Menzies School of Health Research, Darwin, Australia

Melioidosis: priority known unknowns


9:00 am

Alf Fuessel, European Commission, Health and Consumer Protection Directorate-General, Unit 2-Animal Health and Welfare, Brussels, Belgium

Global epidemiology of glanders


9:30 am

Emma Birnie, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands

Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change

Selected Presentations 

10:00 am

Srujana Mohanty, All India Institute of Medical Sciences, Bhubaneswar, India 

Musculoskeletal melioidosis: a single-centre experience from India over a 5-year period

10:15–10:45 am


10:45–12:30 am


Invited Speakers

10:45 am

Karine Laroucau, ANSES Maisons-Alfort, Paris-Est University, Paris, France

Diagnostic challenges in glanders


11:15 am

Narisara Chantratita, Mahidol University, Bangkok, Thailand

Identification of biomarkers for predicting mortality in melioidosis

Selected Presentations

11:45 am

Mindy Elrod, Centers for Disease Control and Prevention, Atlanta, USA

Investigation into aromatherapy spray associated outbreak of melioidosis in the United States in 2021


12:00 am

Nguyen-Ho Lam, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Vietnam

Antimicrobial resistance of Burkholderia pseudomallei causing community-acquired pneumonia


12:15 pm

Kay Barnes, The Defence Science and Technology Laboratory, Salisbury, United Kingdom

Combination antibiotic therapy in a mouse model of inhalational melioidosis

12:30–1:30 pm


1:30–3:00 pm


Invited Speakers

1:30 pm

Jay Gee, Centers for Disease Control and Prevention, Atlanta, USA

Review of genomic analysis of Burkholderia pseudomallei associated with imports to the continental United States 


2:00 pm

Jelmer Savelkoel, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands

A call to action: time to recognise melioidosis as a neglected tropical disease


2:30 pm

Anthony Solomon, World Health Organization, Geneva, Switzerland

Neglected tropical diseases at WHO, and the global NTD road map 2021–2030

3:00–3:30 pm


3:30–4:30 pm

Flash talks 1 (2 slide)
Poster presentation 1


Mégane Gasqué Anticipating emergences: spatial and molecular epidemiology of Melioidosis in French overseas departments and territories. 


Sergei Biryukov Cytokine Profiles of Subunit Hcp1-based and Live Attenuated Bp 668 ΔilvI Candidate Vaccines


Sophie Guillier Characterisation of the genetic evolution of Burkholderia thailandensis upon antibiotic stress


Fabienne Neulat-Ripoll RNAseq analysis on B. pseudomallei clinical isolates and impact of phenothiazines on resistance’s mechanisms


Sabine Lichtenegger B. pseudomallei core genome MLST analysis links melioidosis cases to a predominant genotype in a geographical B. pseudomallei hotspot


Sunee Chayangsu Clinical Prediction Rules for In-hospital Mortality Outcome in Melioidosis Patients 


Bijayini Behera Evaluation of In Vitro Activity of Cefiderocol against Burkholderia pseudomallei by Broth Microdilution and Disk Diffusion

4:30–6:00 pm


Invited Speakers

4:30 pm

Herbert Schweizer, Northern Arizona University, Flagstaff, USA

Novel insights into antibiotic resistance of Burkholderia pseudomallei Complex Species


5:00 pm

Gabriel E. Wagner, Medical University of Graz, Graz, Austria

Point of care tests for melioidosis and glanders

Selected Presentations

5:30 pm

Adam Taylor, The Defence Science and Technology Laboratory, Salisbury & London School of Hygiene and Tropical Medicine, London,  United Kingdom

Antibody-antibiotic conjugate for melioidosis


5:45 pm

Riccardo D’Elia, The Defence Science and Technology Laboratory, Salisbury, United Kingdom

Harnessing natural regulators to combat infectious Diseases

7:30 pm

Conference Dinner

Wednesday, May 18th, 2022

7:30-8:30 am

Registration open

8:30–9:45 am


Invited Speakers

8:30 am

Joanne Stevens, University of Edinburgh, Edinburgh, United Kingdom  

Studies on the actin-based motility and its role in the intracellular survival of Burkholderia pseudomallei


9:00 am

Josh Hanson, Kirby Institute, Sydney, Australia 

Melioidosis of the central nervous system; impact of the bimABm allele on patient presentation and outcome

Selected Presentations 

9:30 am

Patpong Rongkard, University of Oxford, United Kingdom

T-cell dysregulation is associated with fatality in community-acquired melioidosis

9:45–10:15 am


10:15–11:45 am


Invited Speakers 

10:15 am

Claire Chewapreecha, Mahidol University, Bangkok, Thailand 

Genome-wide association study identifies bacterial factors associated with 28-day mortality in melioidosis patients


10:45 am

Rita Oladele, Lagos University Teaching Hospital, Lagos, Nigeria.

Evaluating the presence of Burkholderia pseudomallei in Nigeria: an environmental soil sampling study 

Selected Presentations

11:15 am

Karoline Assig, Medical University of Graz, Graz, Austria 

Environmental factors associated with soil prevalence of the melioidosis pathogen Burkholderia pseudomallei: A longitudinal seasonal study from South West India


11:30 am

Apichai Tuanyok, University of Florida, Gainesville, FL, USA

A Comprehensive Study of Prophage Islands in Burkholderia pseudomallei Complex (BPC)

11:45–12:45 pm


12:45-1:45 pm

Flash talks 2 (2 slides) 

Poster presentation 2 


Hoi Cheung The role of Type VI secretion systems in infection and competition of Burkholderia thailandensis


Miro Plum Type VI secretion system-5 of Burkholderia thailandensis assembles to lyse host cell protrusions


Megan Grund Bucl8-derived intranasal vaccine elicits distinct immune responses in an outbred murine model of melioidosis


Sarah Harding Modelling relapse of disease in a mouse model of melioidosis


Yuli Talyansky Host Background and Bacterial Isolate Determine Virulence and Inflammatory Response in a Burkholderia pseudomallei Mouse Model


Muthita Vanaporn The role of Burkholderia pseudomallei bprE gene in survival under stresses and infection

1:45–3:30 pm


Invited Speakers

1:45 pm

Susie Dunachie, University of Oxford, Oxford, United Kingdom

Vaccines against melioidosis: How far are we?


2:15 pm

Ratanaporn Tangwangvivat, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand

National plan for the prevention and control of melioidosis in Thailand

3:30–4:00 pm


4:00 pm

Concluding Remarks 

Announcement of WMC 2024